Physician profile
John Matthew Felder
NPI 1336373828
$125,612.76
in general payments reported to CMS, 2019-2025
38 companies · $25K in 2025
The $25K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,480 · 2020: $1,755 · 2021: $1,575 · 2022: $42K · 2023: $37K · 2024: $15K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $63K · Food and Beverage: $7,939 · Travel and Lodging: $5,932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $63,470.00 |
| Food and Beverage | $7,938.95 |
| Travel and Lodging | $5,931.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $113,279.54 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Axogen | $2,744.91 | 2019-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Kerecis Limited | $1,675.38 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Elite Orthopedics, LLC | $960.62 | 2020 | |
| Stryker Corporation | $819.95 | 2019-2025 | Spy-Phi System |
| Acera Surgical, INC. | $629.88 | 2019-2025 | Restrata Wound Matrix |
| Polynovo North America LLC | $509.77 | 2021-2025 | Novosorb Btm |
| Davol INC. | $481.37 | 2019-2025 | Arista Ah Flexitip, Phasix Mesh |
| Depuy Synthes Sales INC. | $475.48 | 2023-2025 | Trumatch, Matrixrib |
| Kci USA, INC. | $403.30 | 2020-2023 | V.A.C. Veraflo |
| Baxter Healthcare | $390.37 | 2019-2024 | Artiss |
| Mentor Worldwide LLC | $359.63 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $303.76 | 2023 | |
| Allergan, INC. | $295.33 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $282.96 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $273.97 | 2019-2022 | |
| Aroa Biosurgery Incorporated | $174.24 | 2024 | |
| Sanara Medtech INC. | $174.11 | 2021-2023 | Celleraterx |
| Biocomposites INC | $171.15 | 2019-2024 | |
| Rti Surgical, INC | $157.15 | 2025 | |
| Polarityte, INC. | $135.30 | 2019 | |
| Endo Pharmaceuticals INC. | $135.26 | 2019 | |
| Medela LLC | $121.75 | 2021-2022 | |
| Sientra, INC. | $120.95 | 2022 | |
| Tela Bio, INC. | $99.86 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $84.44 | 2024-2025 | Renasys Touch, Grafix Pl, Grafix |
| Avita Medical Americas, LLC | $71.75 | 2024 | |
| Misonix INC | $67.56 | 2019 | |
| Medtronic, INC. | $45.75 | 2025 | V-Loc 180, Plasmablade(Tm) |
| Organogenesis INC. | $29.11 | 2019 | |
| Ethicon US, LLC | $25.76 | 2025 | Harmonic, Enseal |
| Access Pro Medical, LLC | $21.83 | 2025 | Matriderm |
| Solventum Corporation | $20.10 | 2025 | Activ.A.C. |
| Mckesson Patient Care Solutions INC. | $19.20 | 2019 | |
| Aesculap, INC. | $13.57 | 2024 | Aesculap |
| Convatec INC. | $12.72 | 2019 | |
| Coopersurgical, INC. | $12.50 | 2019 | |
| Genzyme Corporation | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Felder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.